UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

Journal of clinical pharmacology, 2005-05, Vol.45 (5), p.555-565

2005

Volltextzugriff (PDF)

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

Journal of thrombosis and haemostasis, 2005-01, Vol.3 (1), p.103-111

2005

Volltextzugriff (PDF)

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I

Journal of thrombosis and haemostasis, 2004-09, Vol.2 (9), p.1573-1580

2004

Volltextzugriff (PDF)

Prognosis of total hip replacement in Sweden: Follow-up of 92,675 operations performed 1978-1990

Acta orthopaedica, 1993, Vol.64 (5), p.497-506

1993

Volltextzugriff (PDF)

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

Journal of thrombosis and haemostasis, 2003-12, Vol.1 (12), p.2490-2496

2003

Volltextzugriff (PDF)

Multicenter clinical trials and their value in assessing total joint arthroplasty

Clinical orthopaedics and related research, 1989-12, Vol.249 (249), p.48-55

1989

Volltextzugriff (PDF)

Dislocations and the femoral head size in primary total hip arthroplasty

Clinical orthopaedics and related research, 1996-12, Vol.333 (333), p.226-233

1996

Volltextzugriff (PDF)

Prognosis of total hip replacement: A Swedish multicenter study of 4,664 revisions

Acta orthopaedica Scandinavica, 1990-01, Vol.61 (38), p.2-26

1990

Volltextzugriff (PDF)

How far does prophylaxis against infection in total joint replacement offset its cost?

BMJ, 1988-01, Vol.296 (6615), p.99-102

1988

Volltextzugriff (PDF)

Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies

Thrombosis research, 2002-03, Vol.105 (5), p.371-378

2002

Volltextzugriff (PDF)

Surgical experience related to dislocations after total hip arthroplasty

Journal of bone and joint surgery. British volume, 1996-03, Vol.78 (2), p.206-209

1996

Volltextzugriff (PDF)

Incidence of dislocation after hip arthroplasty: Comparison of different registration methods in 408 cases

Acta orthopaedica Scandinavica, 1992-08, Vol.63 (4), p.403-406

1992

Volltextzugriff (PDF)

Re-operation of total hip arthroplasties

Läkartidningen, 1980-07, Vol.77 (30-31), p.2604

1980

Volltextzugriff (PDF)

Revision total hip arthroplasty in patients younger than 55 years old. Clinical and radiologic results after 4 years

The Journal of arthroplasty, 1988, Vol.3 (1), p.47-59

1988

Volltextzugriff (PDF)

Prognosis of total hip replacement

Acta orthopaedica, 1990, Vol.61 (S238), p.2-26

1990

Volltextzugriff (PDF)

Prognosis of total hip replacement. A Swedish multicenter study of 4,664 revisions

Acta orthopaedica Scandinavica. Supplementum, 1990, Vol.238, p.1

1990

Volltextzugriff (PDF)

Prognosis of total hip replacement in Swede : follow-up of 92,675 operations performed 1978-1990

Acta orthopaedica Scandinavica, 1993, Vol.64 (5), p.497-506

1993

Volltextzugriff (PDF)

Hip surgery in Gothenburg up to 1990. Orthopedic surgery resources are needed for the treatment of fractures and arthrosis/arthritis

Läkartidningen, 1984-11, Vol.81 (47), p.4414

1984

Volltextzugriff (PDF)

Multicenter clinical trials and their value in assessing tota joint arthroplasty

Clinical orthopaedics and related research, 1989 (249), p.48-55

1989

Volltextzugriff (PDF)

Symposium. New hip joints: an explosion-like development

Läkartidningen, 1988-09, Vol.85 (38), p.3053

1988

Volltextzugriff (PDF)

Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist

Science translational medicine, 2018-11, Vol.10 (467)

2018

Volltextzugriff (PDF)

An atlas of rabbit development as a model for single-cell comparative genomics

Nature cell biology, 2023-07, Vol.25 (7), p.1061-1072

2023

Volltextzugriff (PDF)

Chemical and biological integration of a mouldable bioactive ceramic material capable of forming apatite in vivo in teeth

Biomaterials, 2004-06, Vol.25 (14), p.2781-2787

2004

Volltextzugriff (PDF)

Pancreatic islet and progenitor cell surface markers with cell sorting potential

Diabetologia, 2012, Vol.55 (1), p.154-165

2012

Volltextzugriff (PDF)

Acetyl-CoA-carboxylase 1 (ACC1) plays a critical role in glucagon secretion

Communications biology, 2022-03, Vol.5 (1), p.238-238, Article 238

2022

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I

Prognosis of total hip replacement in Sweden: Follow-up of 92,675 operations performed 1978-1990

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

Multicenter clinical trials and their value in assessing total joint arthroplasty

Dislocations and the femoral head size in primary total hip arthroplasty

Prognosis of total hip replacement: A Swedish multicenter study of 4,664 revisions

How far does prophylaxis against infection in total joint replacement offset its cost?

Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies

Surgical experience related to dislocations after total hip arthroplasty

Incidence of dislocation after hip arthroplasty: Comparison of different registration methods in 408 cases

Re-operation of total hip arthroplasties

Revision total hip arthroplasty in patients younger than 55 years old. Clinical and radiologic results after 4 years

Prognosis of total hip replacement

Prognosis of total hip replacement. A Swedish multicenter study of 4,664 revisions

Prognosis of total hip replacement in Swede : follow-up of 92,675 operations performed 1978-1990

Hip surgery in Gothenburg up to 1990. Orthopedic surgery resources are needed for the treatment of fractures and arthrosis/arthritis

Multicenter clinical trials and their value in assessing tota joint arthroplasty

Symposium. New hip joints: an explosion-like development

Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist

An atlas of rabbit development as a model for single-cell comparative genomics

Chemical and biological integration of a mouldable bioactive ceramic material capable of forming apatite in vivo in teeth

Pancreatic islet and progenitor cell surface markers with cell sorting potential

Acetyl-CoA-carboxylase 1 (ACC1) plays a critical role in glucagon secretion

Suchergebnisse filtern